Kyron.bio is revolutionising the way we make our therapeutic drugs.
Our novel engineering strategy allows us to precisely control the glycosylation pattern on the surface of a biologic in order to develop the next generation of medicines. This unique approach enables us to sculpt biologics based on the sugars that are attached to the surface, helping to make therapeutics safer and more effective.
Our work at Kyron.Bio is opening up a new era of biologics engineering – one with the power to create positive health outcomes for patients whose needs are currently unserved by the pharmaceutical industry.
Company Details
- Employees
- 9
- Founded
- -
- Address
- 55, Boulevard Vincent Auriol, Paris,île-De-France 75013,france
- Industry
- Biotechnology
- Website
- https://www.kyron.bio/
- Keywords
- Bioproduction and Cell line.
- HQ
- Paris, Île-de-France
Kyron.bio Questions
Kyron.Bio's website is https://www.kyron.bio/
Kyron.Bio's LinkedIn profile is https://fr.linkedin.com/company/kyron-bio
Kyron.Bio has
9 employees.
View email and phone details for 9
employees at Kyron.Bio.
Kyron.Bio's industry is
Biotechnology
Kyron.Bio's top competitors are
Noota,
Pyxiscience,
Veesion,
Spore.bio,
Amatera,
Core Biogenesis,
Endogene.bio,
Hcvc,
Dastra,
Quobly.
Kyron.Bio's categories are Biotechnology
Kyron.Bio's founding year is 2022
